Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B

PHASE4CompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Chronic Hepatitis B
Interventions
DRUG

Entecavir maleate tablets

DRUG

blank Baraclude tablets

DRUG

Blank maleate entecavir tablets

DRUG

Baraclude tablets

Trial Locations (9)

100034

Department of Infectious Diseases,Peking University First Hospital, Beijing

100054

Beijing You An Hospital,Capital Medical University, Beijing

200025

Shanghai Jiaotong University Affiliated Ruijin Hospital, Shanghai

210029

The First Affiliated Hospital Of Nanjing Medical University, Nanjing

310003

The First Affiliated Hospital Of Zhejiang University, Hangzhou

400010

The Second Affiliated Hospital Of Chongqing Medical University, Chongqing

West China Hospital Of Sichuan University, Chongqing

400038

The First Affiliated Hospital Of The Third Mililary Medical University, Chongqing

430030

Tongji Medical College of Hust Tongji Medical College Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY